Schedule 13G ownership disclosure

INDIVIOR PLC

Ordinary Shares · CUSIP: G4766E116

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 4,665,206 · Class: 3.7%

  • Morgan Stanley & Co. International plc

    Shares: 3,972,198 · Class: 3.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000349
Form type
SCHEDULE 13G/A
Filer
Indivior Pharmaceuticals, Inc.
CIK
CIK 1625297
Filed
May 06, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub